Andreas Suhrbier
More
About
Prof Andreas Suhrbier is Group Leader of the Inflammation Biology Group at the QIMR Berghofer Medical Research Institute, Brisbane, Australia, and a Principal Research Fellow with the National Health & Medical Research Council (Australia). He has over 140 publications in the fields of virology, immunology and cancer therapeutics. He is an inventor on 17 patents, 12 have been commercialised, 7 cover products in human clinical trials, 5 cover ingenol mebutate/Picato, a topical anti-cancer agent recently approved in the USA, EU and Australia. He is, and has been a consultant for, and conducted collaborative R&D with, a number of local and international biotech and pharma companies.
Joined
March 2016